Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016
Open accessThe DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
Background: The emergence of antifungal resistance threatens effective treatment of invasive fungal infection (IFI). Invasive candidiasis is the most common health care–associated IFI. We evaluated the activity of fluconazole (FLU) against 20 788 invasive isolates of Candida (37 species) collected from 135 medical centers in 39 countries (1997–2016). The activity of anidulafungin, caspofungin, and micafungin (MCF) was evaluated against 15 308 isolates worldwide (2006–2016). Methods: Species identification was accomplished using phenotypic (1997–2001), genotypic, and proteomic methods (2006–2016). All isolates were tested using reference methods and clinical breakpoints published in the Clinical and Laboratory Standards Institute documents. Results: A decrease in the isolation of Candida albicans and an increase in the isolation of Candida glabrata and Candida parapsilosis were observed over time. Candida glabrata was the most common non–C. albicans species detected in all geographic regions except for Latin America, where C. parapsilosis and Candida tropicalis were more common. Six Candida auris isolates were detected: 1 each in 2009, 2013, 2014, and 2015 and 2 in 2016; all were from nosocomial bloodstream infections and were FLU-resistant (R). The highest rates of FLU-R isolates were seen in C. glabrata from North America (NA; 10.6%) and in C. tropicalis from the Asia-Pacific region (9.2%). A steady increase in isolation of C. glabrata and resistance to FLU was detected over 20 years in the United States. Echinocandin-R (EC-R) ranged from 3.5% for C. glabrata to 0.1% for C. albicans and C. parapsilosis. Resistance to MCF was highest among C. glabrata (2.8%) and C. tropicalis (1.3%) from NA. Mutations on FKS hot spot (HS) regions were detected among 70 EC-R isolates (51/70 were C. glabrata). Most isolates harboring FKS HS mutations were resistant to 2 or more ECs. Conclusions: EC-R and FLU-R remain uncommon among contemporary Candida isolates; however, a slow and steady emergence of resistance to both antifungal classes was observed in C. glabrata and C. tropicalis isolates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Historically this organism has been pan-susceptible to triazoles, echinocandins, and amphotericin B.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [62]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“In the US, fluconazole resistance rates range between 4–10%; rates are much higher in other parts of the world including Japan, Western Europe, and Latin America.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [62]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“In the US, fluconazole resistance rates range between 4–10%; rates are much higher in other parts of the world including Japan, Western Europe, and Latin America.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [62]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although relatively low levels of resistance for most Candida species have been described, the outcomes for candidemia remain poor, as high levels of mortality (15%-50%) have been associated with candida infections7.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In this Review, we explore the molecular mechanisms that contribute to antifungal drug resistance, with a focus on Candida spp., the most common cause of fungal infections in humans7.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [7]
Experimental — accuracy not yet measured
22 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 2×
“Sentinel surveillance programs designed to capture organisms and patient demographic data from representative sites spanning a larger geographical area and over a longer period of time serve to fill the gaps in time and space that are necessarily left by the more intensive and focused, yet intermittent, population-bas…”
BackgroundSelf-citationPappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953 · cited 1×
“The burden of invasive fungal infections (IFIs) for patients and health care systems is difficult to measure [2, 12]; however, it is well recognized that IFIs are associated with high morbidity and mortality rates and elevated health care costs.”
BackgroundLockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662 · cited 2×
“S90 • OFID 2019:6 (Suppl 1) • Pfaller et al SENTRY Program Candida Surveillance (1997–2016) • OFID 2019:6 (Suppl 1) • S91 [93, 94], and emerging resistance mechanisms [20, 68] highlight the importance of local and global surveillance studies.”
BackgroundSelf-citationKullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1194 · Cited by 1,298
Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217 · cited 1×
“Caspofungin, micafungin, and anidulafungin were approved for clinical use by the US Food and Drug Administration (FDA) in 2001, 2005, and 2006, respectively, and are now recommended as firstline agents for treating IC [50, 67].”
BackgroundCalderone, R. (2012) · ASM Press eBooks · Cited by 912
Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment
Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903
Self-citation
Research works printed but not linked: 4
- 38. CLSI. M27-S4. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: 4th Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
- 39. CLSI. M27-A3. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
- 40. CLSI. M59. Epidemiological Cutoff Values for Antifungal Susceptibility Testing. 1st ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2016.
- 63. Pfaller MA, Diekema DJ Azole antifungal drug cross-resistance: mechanisms epidemiology, and clinical significance. J Invasive Fungal Infect 2007; 1: 74– 92.
Cited by
Items 301–400 of 931
Unconventional Yeasts Isolated from Chilean Honey: A Probiotic and Phenotypic Characterization
Machado, A. R., Mella, C., Hurtado-Murillo, J. J., Gomes-Lobo, C. J., Zúñiga, R. N., & Franco, W. (2024) · Foods · doi:10.3390/foods13101582 · Cited by 18
Arastehfar, A. A., Marcet‐Houben, M., Daneshnia, F., Taj‐Aldeen, S. J., Batra, D. G., Lockhart, S. R., Shor, E., Gabaldón, T., & Perlin, D. S. (2021) · Studies in Mycology · doi:10.1016/j.simyco.2021.100133 · Cited by 18
Gaspar‐Cordeiro, A., Amaral, C., Pobre, V., Antunes, W., Petronilho, A., Paixão, P., Matos, A., & Pimentel, C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.920574 · Cited by 18
Asadzadeh, M., Alfouzan, W. A., Parker, J. E., Meis, J. F. G. M., Kelly, S. L., Joseph, L., & Ahmad, S. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01474-23 · Cited by 18
Pfaller, M. A., Carvalhaes, C. G., Messer, S. A., Rhomberg, P. R., & Castanheira, M. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115473 · Cited by 18
Self-citationA Proteomic Landscape of Candida albicans in the Stepwise Evolution to Fluconazole Resistance
Song, N., Zhou, X., Li, D., Li, X., & Liu, W. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02105-21 · Cited by 17
Emerging antifungal resistance in Candida parapsilosis: the end of the innocence
Guinea, J., Escribano, P., Cadeau, M., Lombardi, L., & Morio, F. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00173-5 · Cited by 18
Bhakt, P., Raney, M., & Kaur, R. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102485 · Cited by 17
Guevara-Lora, I., Braś, G., Juszczak, M., Karkowska‐Kuleta, J., Górecki, A., Manrique-Moreno, M., Dymek, J., Pyza, E., Kozik, A., & Rąpała‐Kozik, M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1045984 · Cited by 17
Effect of Star Topology Versus Linear Polymers on Antifungal Activity and Mammalian Cell Toxicity
Schaefer, S., Melodia, D., Corrigan, N. A., Lenardon, M. D., & Boyer, C. A. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202300452 · Cited by 17
Fungal Infections, Treatment and Antifungal Resistance: The Sub-Saharan African Context
Boakye-Yiadom, E., Odoom, A., Osman, A.-H., Ntim, O. K., Kotey, F. C. N., Ocansey, B. K., & Donkor, E. S. (2024) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361241297525 · Cited by 17
Asadzadeh, M., DASHTI, M. H., Ahmad, S., Alfouzan, W. A., & Alameer, A. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01633-20 · Cited by 17
Sinh, C. T., Loi, C. B., Minh, N. T., Lam, N. N., Quang, D. X., Đỗ, Q., Ánh, Đ. N., Hien, T. T. T., Su, H. X., & Le, T. (2021) · Mycopathologia · doi:10.1007/s11046-021-00569-7 · Cited by 17
Sakamoto, Y., Kawabe, K., Suzuki, T., Sano, K., Ide, K., Nishigaki, T., Enoki, Y., Taguchi, K., Koike, H., Kato, H., et al. (2021) · Journal of Fungi · doi:10.3390/jof7080596 · Cited by 17
Biofilm-formation capability depends on environmental oxygen concentrations in Candida species
Koshikawa, T., Abe, M., Nagi, M., Miyazaki, Y., & Takemura, H. (2022) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2022.01.010 · Cited by 17
Schrevens, S., Durandau, E., Tran, V. D. T., & Sanglard, D. (2022) · Virulence · doi:10.1080/21505594.2022.2095716 · Cited by 17
Glushakova, A. M., & Качалкин, А. В. (2023) · International Microbiology · doi:10.1007/s10123-023-00437-y · Cited by 17
Xu, H., Yu, S.-Y., Zhou, M., Ning, Y., Xiao, M., Li, X.-G., Chen, M., Kong, F., Chen, S. C.-J., Ming, L., et al. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s227839 · Cited by 17
SUMOylation in Human Pathogenic Fungi: Role in Physiology and Virulence
Sahu, M. S., Patra, S., Kumar, K., & Kaur, R. (2020) · Journal of Fungi · doi:10.3390/jof6010032 · Cited by 17
Effect of Dermaseptin S4 on C. albicans Growth and EAP1 and HWP1 Gene Expression
Samot, J., & Rouabhia, M. (2020) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-020-09685-0 · Cited by 17
Schikora-Tamarit, M. À., Marcet-Houben, M., Nosek, J., & Gabaldón, T. (2021) · Open Biology · doi:10.1098/rsob.200362 · Cited by 16
Naskar, S., Prajapati, A., & Kaur, R. (2025) · FEMS Yeast Research · doi:10.1093/femsyr/foaf025 · Cited by 17
Muzio, L. D., Cairone, F., Cesa, S., Sergi, C., Tirillò, J., Angiolella, L., Giammarino, A., Giusiano, G., Petralito, S., Casadei, M. A., et al. (2024) · Carbohydrate Polymer Technologies and Applications · doi:10.1016/j.carpta.2024.100485 · Cited by 16
Hassoun, Y., Aptekmann, A. A., Keniya, M. V., Gomez, R. Y., Alayo, N., Novi, G., Quinteros, C., Kaya, F., Zimmerman, M. D., Cáceres, D. H., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012521 · Cited by 16
Mutational landscape and molecular bases of echinocandin resistance in Saccharomyces cerevisiae
Durand, R., Torbey, A. G., Giguère, M., Pageau, A., Dubé, A. K., Lagüe, P., & Landry, C. R. (2026) · Genetics · doi:10.1093/genetics/iyag055 · Cited by 16
An evaluation of ibrexafungerp for the treatment of invasive candidiasis: the evidence to date
Colombo, R. E., & Vázquez, J. A. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1890026 · Cited by 16
Szarvas, J., Rebelo, A. R., Bortolaia, V., Leekitcharoenphon, P., Hansen, D. S., Nielsen, H. L., Nørskov‐Lauritsen, N., Kemp, M., Røder, B. L., Møller, J. K., et al. (2021) · Journal of Fungi · doi:10.3390/jof7110962 · Cited by 16
de la Rosa‐García, E., Olalde‐Hernández, M. J., Irigoyen‐Camacho, M. E., Padilla, A. M., Mendoza-Juache, A., & Sánchez-Vargas, L. O. (2020) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2020.101009 · Cited by 16
Vij, R., Hube, B., & Brunke, S. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.02.003 · Cited by 16
Bing, J., Li, S., Ji, L., Du, H., Shamoon, N. M., Nobile, C. J., & Huang, G. (2026) · Clinical Microbiology Reviews · doi:10.1128/cmr.00394-25 · Cited by 15
A Deep Learning Approach to Capture the Essence of Candida albicans Morphologies
Bettauer, V., Costa, A. C. B. P., Omran, R. P., Massahi, S., Kirbizakis, E., Simpson, S., Dumeaux, V., Law, C. O., Whiteway, M. S., & Hallett, M. T. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01472-22 · Cited by 15
Kulig, K., Rąpała‐Kozik, M., & Karkowska‐Kuleta, J. (2024) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2024.100255 · Cited by 16
Ellagic Acid Potentiates the Inhibitory Effects of Fluconazole Against Candida albicans
Mendes, A. G. G., Campos, C. D. L., Filho, J. L. P., Pereira, A. P. A., Reis, G. S. A., Araújo, Á. W. M. D. S., Monteiro, P. D. M., Vidal, F. C. B., Monteiro, S. G., Figueiredo, I. F. D. S., et al. (2024) · Antibiotics · doi:10.3390/antibiotics13121174 · Cited by 16
Sahoo, B., Goyal, R., Dutta, S., Joshi, P., & Sanyal, K. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c00079 · Cited by 15
Zoppo, M., Poma, N. V., Luca, M. D., Bottai, D., & Tavanti, A. (2021) · Journal of Fungi · doi:10.3390/jof7060459 · Cited by 15
Jeon, S., Shin, J. H., Lim, H. J., Choi, M. J., Byun, S. A., Lee, D., Lee, S. Y., Won, E. J., Kim, S. H., & Shin, M. (2021) · Annals of Laboratory Medicine · doi:10.3343/alm.2021.41.6.559 · Cited by 15
Sığ, A. K., Sönmezer, M. Ç., Gülmez, D., Duyan, S., Uzun, Ö., & Arıkan-Akdağlı, S. (2021) · Journal of Fungi · doi:10.3390/jof7090691 · Cited by 15
Molecular Phylogenetic Analysis of Candida krusei
Domán, M., Makrai, L., & Bànyai, K. (2022) · Mycopathologia · doi:10.1007/s11046-022-00640-x · Cited by 15
Fais, R., Rizzato, C., Franconi, I., Tavanti, A., & Lupetti, A. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01240-22 · Cited by 15
Ortíz, B., Aguilar, K., Galindo, C., Molina, L., & Fontecha, G. A. (2022) · Current Medical Mycology · doi:10.18502/cmm.8.3.11212 · Cited by 15
Materials used to prevent adhesion, growth, and biofilm formation ofCandidaspecies
Tornero-Gutiérrez, F., Ortiz-Ramírez, J. A., López-Romero, E., & Cuéllar‐Cruz, M. (2023) · Medical Mycology · doi:10.1093/mmy/myad065 · Cited by 15
Wang, Y., Xu, J., Abid, F. B., Salah, H., Sundararaju, S., Ismail, K. A., Wang, K., Matthew, L. S., Taj‐Aldeen, S. J., Ibrahim, E. B., et al. (2024) · Microbial Genomics · doi:10.1099/mgen.0.001179 · Cited by 15
Jung, I. Y., Jeong, S. J., Kim, Y. K., Kim, H. Y., Song, Y. G., Kim, J. M., & Choi, J. Y. (2020) · Medicine · doi:10.1097/md.0000000000019494 · Cited by 16
Alvarado, M., Navajas, J. A. G., Muñoz, M. T. B., Gómez-Molero, E., Fernández-Sánchez, S., Eraso, E., Munro, C. A., Valentín, E., Mateo, E., & de Groot, P. W. J. (2024) · FEMS Yeast Research · doi:10.1093/femsyr/foae039 · Cited by 14
Genotypic and Phenotypic Changes in Candida albicans as a Result of Cold Plasma Treatment
Tyczkowska-Sieroń, E., Kałużewski, T., Grabiec, M., Kałużewski, B., & Tyczkowski, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218100 · Cited by 14
Katsiari, M., Nikolaou, C., Palla, E., Theodoridou, K., Tsakris, A., & Vrioni, G. (2025) · Pathogens · doi:10.3390/pathogens14040328 · Cited by 13
“Multidrug and pan drug resistance are seen in 41% and 3–4% of the strains [11,26,27].”
Yu, S. N., Hong, S. I., Park, J. W., Jeon, M. H., & Cho, O. (2025) · Journal of Fungi · doi:10.3390/jof11030217 · Cited by 13
Jain, K., Wadhwa, K., MALIK, M. L., Haque, S., Prieto, M. A., & Kaur, H. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf742 · Cited by 13
Host-pathogen interactions: lessons from phagocytic predation on fungi
Radosa, S., & Hillmann, F. (2021) · Current Opinion in Microbiology · doi:10.1016/j.mib.2021.04.010 · Cited by 13
Memon, S., Farooqi, J. Q., Zafar, U., Naqvi, S. F., Zafar, A., & Jabeen, K. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001459 · Cited by 14
Späth, G. F., & Bussotti, G. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1237 · Cited by 13
Zhu, X., Li, Y., Zhang, X., Zhang, P., Tian, Q., Ma, C., & Shi, C. (2023) · Current Microbiology · doi:10.1007/s00284-023-03198-z · Cited by 13
Pedro, N. A., Fontebasso, G., Pinto, S. N., Alves, M. M., & Mira, N. P. (2023) · Microbial Cell · doi:10.15698/mic2023.04.795 · Cited by 13
Hubler, C. M., Carvalhaes, C. G., & Castanheira, M. (2023) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2023.115957 · Cited by 13
Self-citationDiscovery of a new chemical scaffold for the treatment of superbug Candida auris infections
Tu, J., Zhu, T., Wang, Q., Yang, W., Huang, Y., Xu, D., Liu, N., & Sheng, C. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2208687 · Cited by 13
Chesdachai, S., Yetmar, Z. A., Ranganath, N., Everson, J. J., Wengenack, N. L., & Saleh, O. A. (2023) · Journal of Fungi · doi:10.3390/jof9080821 · Cited by 14
Caetano, C. F., Gaspar, C., Oliveira, A. S., Palmeira‐de‐Oliveira, R., Rodrigues, L., Gonçalves, T., Martinez‐de‐Oliveira, J., Palmeira‐de‐Oliveira, A., & Rolo, J. (2023) · Microorganisms · doi:10.3390/microorganisms11102398 · Cited by 13
Verma, N., Riyaz, M., Kaur, G., Negi, P., Ghawri, H., & Raj, K. (2024) · Indian Journal of Microbiology · doi:10.1007/s12088-024-01277-8 · Cited by 13
Ahaik, I., Nunez‐Rodriguez, J. C., Abrini, J., Bouhdid, S., & Gabaldón, T. (2024) · Journal of Fungi · doi:10.3390/jof10060373 · Cited by 13
Secondary Metabolites from Marine-Derived Fungus Penicillium rubens BTBU20213035
Xu, X., Dong, Y., Yang, J., Wang, L., Ma, L., Song, F., & Ma, X. (2024) · Journal of Fungi · doi:10.3390/jof10060424 · Cited by 13
Khan, Z., Ahmad, S., Al‐Sweih, N., Mokaddas, E. M., Al-Banwan, K., Alfouzan, W. A., Al‐Obaid, I., Alobaid, K., & Varghese, S. (2020) · Microbial Drug Resistance · doi:10.1089/mdr.2019.0437 · Cited by 13
Aguilar, G., Araujo, P., Lird, G., Insaurralde, S., Kawabata, A., Ayala, E., Irala, J. D., & Argüello, R. (2020) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2020.34 · Cited by 13
Light-induced antifungal activity of nanoparticles with an encapsulated porphyrin photosensitizer
Kodedová, M., Liška, V., Mosinger, J., & Sychrová, H. (2023) · Microbiological Research · doi:10.1016/j.micres.2023.127303 · Cited by 13
Khodavaisy, S., Badali, H., Meis, J. F. G. M., Modiri, M., Mahmoudi, S., Abtahi, H., Salehi, M., Manshadi, S. A. D., Aala, F., Afshari, S. A. K., et al. (2020) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2020.100968 · Cited by 13
Antifungal pipeline: Is there light at the end of the tunnel?
Schinas, G., Spernovasilis, N. A., & Akinosoglou, K. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i16.2686 · Cited by 13
Nickels, T. J., Gale, A. N., Harrington, A. A., Timp, W., & Cunningham, K. W. (2024) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkae173 · Cited by 12
The first prevalence and antifungal susceptibility profile of Candida infections in Palestine, 2022
Baniodeh, H., Abu‐Helu, R., Abulihya, M. W., Awwad, M. Y., Dawoud, A., Tebbji, F., & Sellam, A. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-10062-3 · Cited by 14
Bassetti, M., Stewart, A. G., Bartalucci, C., Vena, A., Giacobbe, D. R., & Roberts, J. A. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2424899 · Cited by 12
The In Vitro Activity of Rezafungin Against Uncommon Species of Candida
Winkler, M., Rhomberg, P. R., Klauer, A., Edeker, S., & Castanheira, M. (2024) · Mycoses · doi:10.1111/myc.70001 · Cited by 12
Self-citationCurrent Antifungals and the Developing Pipeline
Johnson, M. D., & Moore, W. J. (2025) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2025.01.001 · Cited by 13
Developing the trehalose biosynthesis pathway as an antifungal drug target
Washington, E. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00095-2 · Cited by 13
Siswina, T., Rustama, M. M., Sumiarsa, D., & Kurnia, D. (2022) · F1000Research · doi:10.12688/f1000research.125645.1 · Cited by 12
Nishida, R., Eriguchi, Y., Miyake, N., Nagasaki, Y., Yonekawa, A., Mori, Y., Kato, K., Akashi, K., & Shimono, N. (2023) · Medical Mycology · doi:10.1093/mmy/myad056 · Cited by 12
Wang, Q., Tu, J., Yang, W., Liang, T., Liu, N., & Sheng, C. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00488 · Cited by 12
Molecular epidemiology and antimicrobial resistance of vaginal Candida glabrata isolates in Namibia
Dunaiski, C. M., Kock, M. M., Chan, W. Y., Ismail, A., & Peters, R. P. H. (2024) · Medical Mycology · doi:10.1093/mmy/myae009 · Cited by 12
Boyer, J., Hoenigl, M., & Kriegl, L. (2024) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2024.2317293 · Cited by 12
The TAC1 Gene in Candida albicans : Structure, Function, and Role in Azole Resistance: A Mini-Review
Mahdizade, A. H., Hoseinnejad, A., Ghazanfari, M., Boozhmehrani, M. J., Bahreiny, S. S., Abastabar, M., Galbo, R., Giuffrè, L., Haghani, I., & Romeo, O. (2024) · Microbial Drug Resistance · doi:10.1089/mdr.2023.0334 · Cited by 12
de Souza, C. M., Perini, H. F., Verri, W. A., Jr., Zaninelli, T. H., Furlaneto-Maia, L., & Furlaneto, M. C. (2020) · Mycopathologia · doi:10.1007/s11046-020-00504-2 · Cited by 12
Kaan, Ö., Koç, A. N., Atalay, M. A., & Sarıgüzel, F. M. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104870 · Cited by 12
Khan, D., Nile, A. H., Tripathi, A., & Bankaitis, V. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136754 · Cited by 12
Knoll, M. A., Lackner, N., Ulmer, H., Samardzic, E., Steinmann, J., Krause, R., Verhasselt, H. L., Rath, P., Fuchs, F., Koehler, P. A., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.04.014 · Cited by 12
Alternative and Classical Processes for Disinfection of Water Polluted by Fungi: A Systematic Review
Caicedo-Bejarano, L. D., Morante-Caicedo, A., Narváez, S. P. C., & Serna-Galvis, E. A. (2024) · Water · doi:10.3390/w16070936 · Cited by 11
Melinte, V., Tudor, A. D., Bujoi, A. G., Radu, M. T., Văcăroiu, C. M., Cismaru, I. M., Holban, T. S., Mîrzan, L., Popescu, R., Ciupan, R. C., et al. (2024) · Antibiotics · doi:10.3390/antibiotics13040325 · Cited by 11
ElFeky, D. S., El-Wakil, D. M., Mwafy, M. M., Atia, M. M. A., & Gohar, N. M. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-024-10435-8 · Cited by 11
Invasive Candida infections in solid organ transplant recipients between 2008 and 2020
Meyer, L., Frossard, J., Schreiber, P. W., Manuel, O., Lamoth, F., Khanna, N., Boggian, K., Walti, L. N., Garzoni, C., van Delden, C., et al. (2025) · American Journal of Transplantation · doi:10.1016/j.ajt.2025.07.2480 · Cited by 11
Aguirre-Guataqui, K., Márquez-Torres, M., Pineda‐Castañeda, H. M., Vargas‐Casanova, Y., Ceballos-Garzón, A., Monroy, Z. J. R., García‐Castañeda, J. E., & Parra‐Giraldo, C. M. (2022) · Antibiotics · doi:10.3390/antibiotics11111561 · Cited by 11
Chastain, D. B., White, B. P., Tu, P. J., Chan, S., Jackson, B., Kubbs, K. A., Bandali, A., McDougal, S., Henao‐Martínez, A. F., & Cluck, D. B. (2023) · Annals of Pharmacotherapy · doi:10.1177/10600280231175201 · Cited by 11
Expression of ERG11, ERG3, MDR1 and CDR1 genes in Candida tropicalis
Rodríguez, A. E. R., Cárdenas, L. Y., García, M. C., & Pérez, J. E. (2023) · Biomédica · doi:10.7705/biomedica.6852 · Cited by 11
SWI/SNF complex-mediated chromatin remodeling in Candida glabrata promotes immune evasion
Kumar, K., Pareek, A., & Kaur, R. (2024) · iScience · doi:10.1016/j.isci.2024.109607 · Cited by 11
The Increasing Trend of Triazole-Resistant Candida from Vulvovaginal Candidiasis
Li, L., Zhang, X., Li, Q., Zhong, W., & Zou, H. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s474304 · Cited by 11
Jain, K., Wang, Y., Jain, P., Kalita, B., Shivarathri, R., Chauhan, M., Kaur, H., Chauhan, N., Xu, J., & Chowdhary, A. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01709-24 · Cited by 11
An update on newer antifungals
Akinosoglou, K., Papageorgiou, D., Gogos, C. A., & Dimοpoulos, G. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2461566 · Cited by 11
Silva, R., Silva, N. B. S., Martins, C. H. G., Pires, R. H., Röder, D. V. D. D. B., & Pedroso, R. D. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091872 · Cited by 11
Epidemiological Attributes of Candida Species in Tropical Regions
Bohner, F., Gácser, A., & Tóth, R. (2021) · Current Tropical Medicine Reports · doi:10.1007/s40475-021-00226-5 · Cited by 11
Trovato, L., Bongiorno, D., Calvo, M., Migliorisi, G., Borraccino, A., Musso, N., Oliveri, S. M., Stefani, S., & Scalia, G. (2021) · Journal of Fungi · doi:10.3390/jof7060405 · Cited by 11
Morávková, M., Huvarová, V., Vlková, H., Kostovová, I., & Bačová, R. (2021) · Medical Mycology · doi:10.1093/mmy/myab036 · Cited by 11
Wu, Y., Zou, Y., Dai, Y., Lu, H., Zhang, W., Chang, W., Wang, Y., Nie, Z., Wang, Y., & Jiang, X. (2025) · PLOS Pathogens · doi:10.1371/journal.ppat.1013220 · Cited by 10
“Alarmingly, the resistance of C. tropicalis to azoles has also been on the rise, posing a significant challenge to the treatment of these infections in Asia-Pacific regions [2,4].”
Liang, T., Tu, J., He, Q., Zou, P., Yang, W., Huang, Y., Liu, N., & Sheng, C. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00005 · Cited by 10
Tsai, D. H., Wu, I. C.-Y., Chang, L.-F., Lu, M. J.-H., Debnath, B., Govender, N. P., Sharland, M., Warris, A., Hsia, Y., & Ferreras-Antolin, L. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf329 · Cited by 10
Kılbaş, İ., Kilbaş, E. P. K., Horhat, F. G., & Çiftçi, İ. H. (2025) · Journal of Fungi · doi:10.3390/jof11080603 · Cited by 10
Metadata
- Authors
- Pfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N.
- Affiliations
- University of Iowa (US)
- The University of Adelaide (AU)
- JMI Laboratories (US)
- Corresponding author
- Pfaller, Michael A
- Venue
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-03
- Volume
- 6
- Issue
- Supplement_1
- Pages
- S79-S94
- ISSN
- 2328-8957 (ISSN-L)
- PMC
- PMC6419901
- OpenAlex
- W2922388167
- Semantic Scholar
- b99f36f4463b9afe6d2a0ab52eebb3f5e726f4c0
- Cited by
- 825
- References
- 114
- Citations by year
- 2026: 92 · 2025: 129 · 2024: 133 · 2023: 141 · 2022: 94 · 2021: 108 · 2020: 104 · 2019: 24
- FWCI
- 63.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Open Forum Infectious Diseases (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- JMI Laboratories
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- invasive candidiasis, Candida species, antifungal resistance, fluconazole resistance, echinocandin resistance, Candida glabrata, Candida albicans, Candida parapsilosis, Candida tropicalis, Candida auris, micafungin resistance, caspofungin, anidulafungin, Candida species distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.